GINS2 and neoplasm: Subtypes with rich stromal components (e.g. GINS2 and GINS4) in human CRC samples were inclined to transform into subtypes with high tumor purity (e.g. GINS1 and GINS3) in corresponding PDX derivatives (Figure 10B).